Menu
Peptide Database
Results
No peptides found
Featured

Use search to browse all 100+ peptides

Kisspeptin-10

KP-10, Metastin (45-54), Kisspeptin-10 (human), KiSS-1

Quick Stats
Studies 877
Trials 47
Completed PHASE3 INTERVENTIONAL NCT03771326

KP-10 and Insulin Secretion in Men

View on ClinicalTrials.gov Updated Dec 15, 2025

Brief Summary

Induction of insulin secretion by kisspeptin is observed in mouse, pig, rat, and human islets in vitro and in rats, mice and monkeys in vivo, but its mechanism is not fully clear. The present study was designed to investigate the role of KP-10 on insulin secretion in adult healthy and obese men with insulin resistance. The aim of selection of obese persons for the present study was to investigate the effect of acute KP-10 administration in a metabolically challenged condition where the pancreatic beta cells are already highly activated. The long-term objective of this study was to understand the physiological role of kisspeptin signalling in the regulation of insulin secretion in human health and disease.

Interventions

Name: Kisspeptin-10
Type: BIOLOGICAL
Description: Kisspeptin-10 (metastin 45-54, Calbiochem, Darmstadt, Germany)

Primary Outcomes

Measure: Changes in the response of insulin secretion to acute exogenous kisspeptin administration
TimeFrame: Each participant was studied up to 4 hours. Blood samples from each individual was collected for 30 minutes pre and 120 minutes post KP-10 administration, at 30 minutes interval.
Description: The blood samples were obtained and analysed for insulin by Enzyme Linked Immunosorbent Assay to know the differential response of insulin secretion to exogenous kisspeptin-10 administration in healthy and obese men.

Trial Information

NCT ID

NCT03771326

Status

Completed

Study Type

INTERVENTIONAL

Phases

PHASE3

Sponsor

Quaid-e-Azam University

Last Updated

December 15, 2025